Great Lakes Advisors’s GSK GSK Stock Holding History

Great Lakes Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.04M	Buy	58,000 +2,978	+5%	+$157K	0.02%	342
2026 Q1	$3.04M	Buy	55,022 +1,944	+4%	+$105K	0.03%	340
2025 Q4	$2.6M	Buy	53,078 +3,799	+8%	+$177K	0.02%	375
2025 Q3	$2.13M	Buy	49,279 +17,273	+54%	+$675K	0.02%	424
2025 Q2	$1.23M	Buy	+32,006	New	+$1.22M	0.01%	494
2013 Q4	–	Sell	-3,314	Closed	-$208K	–	382
2013 Q3	$208K	Sell	3,314 -152	-4%	-$9.78K	0.01%	358
2013 Q2	$217K	Buy	+3,466	New	+$220K	0.01%	349

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Great Lakes Advisors's GSK Position: Q2 2026 in Review

Great Lakes Advisors increased its GSK (GSK) stake by 5.4% in Q2 2026, buying an estimated $157K and bringing the position to 58,000 shares worth $3.04M. The position accounts for 0.02% of the portfolio, ranked #342.

Great Lakes Advisors first reported a position in GSK in Q2 2013 and has held it in 7 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Great Lakes Advisors held 58,000 shares of GSK worth $3.04M as of Q2 2026.
Great Lakes Advisors bought 2,978 GSK shares in Q2 2026, an estimated $157K.
GSK made up 0.02% of Great Lakes Advisors's portfolio in Q2 2026, its #342 holding.
Great Lakes Advisors first reported a position in GSK in Q2 2013 and has held it in 7 quarters since.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.